| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B ATP6V1A KIF23 KIF27 SMCHD1 KIF21A RNF213 RUVBL2 ABCA8 ATP2C2 ACIN1 DDX41 DDX4 | 6.27e-06 | 441 | 130 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ATP6V1A KIF23 KIF27 SMCHD1 KIF21A RNF213 RUVBL2 ABCA8 ATP2C2 ACIN1 DDX41 DDX4 | 1.88e-04 | 614 | 130 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 4.15e-04 | 5 | 130 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.67e-04 | 151 | 130 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B ATP6V1A KIF23 KIF27 SMCHD1 KIF21A RNF213 RUVBL2 ABCA8 ATP2C2 ACIN1 GNB1 DDX41 DDX4 | 5.32e-04 | 775 | 130 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.20e-04 | 6 | 130 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | glycerol channel activity | 8.65e-04 | 7 | 130 | 2 | GO:0015254 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.06e-03 | 31 | 130 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.13e-03 | 70 | 130 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B ATP6V1A KIF23 KIF27 SMCHD1 KIF21A RNF213 RUVBL2 ABCA8 ATP2C2 ACIN1 GNB1 DDX41 DDX4 | 1.15e-03 | 839 | 130 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B ATP6V1A KIF23 KIF27 SMCHD1 KIF21A RNF213 RUVBL2 ABCA8 ATP2C2 ACIN1 GNB1 DDX41 DDX4 | 1.16e-03 | 840 | 130 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B ATP6V1A KIF23 KIF27 SMCHD1 KIF21A RNF213 RUVBL2 ABCA8 ATP2C2 ACIN1 GNB1 DDX41 DDX4 | 1.16e-03 | 840 | 130 | 14 | GO:0016818 |
| Domain | WD40_repeat | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 HERC2 GNB1 TBL1X DCAF12 | 4.48e-07 | 272 | 130 | 12 | IPR001680 |
| Domain | Kelch_1 | 5.60e-07 | 70 | 130 | 7 | PF01344 | |
| Domain | Kelch_1 | 5.60e-07 | 70 | 130 | 7 | IPR006652 | |
| Domain | WD_REPEATS_1 | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 HERC2 GNB1 TBL1X DCAF12 | 5.65e-07 | 278 | 130 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 HERC2 GNB1 TBL1X DCAF12 | 5.87e-07 | 279 | 130 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 HERC2 GNB1 TBL1X DCAF12 | 5.87e-07 | 279 | 130 | 12 | PS50294 |
| Domain | WD40_repeat_dom | KIF21B IFT172 KIF21A EML2 LRRK1 TBL1XR1 CFAP52 DCAF12L1 CSTF1 GNB1 TBL1X DCAF12 | 1.14e-06 | 297 | 130 | 12 | IPR017986 |
| Domain | WD40 | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 GNB1 TBL1X DCAF12 | 2.00e-06 | 259 | 130 | 11 | PF00400 |
| Domain | WD40 | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 GNB1 TBL1X DCAF12 | 2.78e-06 | 268 | 130 | 11 | SM00320 |
| Domain | Kelch | 3.05e-06 | 58 | 130 | 6 | SM00612 | |
| Domain | - | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 GNB1 PLXNA2 TBL1X DCAF12 | 3.72e-06 | 333 | 130 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 GNB1 PLXNA2 TBL1X DCAF12 | 3.95e-06 | 335 | 130 | 12 | IPR015943 |
| Domain | BTB-kelch_protein | 1.18e-05 | 43 | 130 | 5 | IPR017096 | |
| Domain | WD40_repeat_CS | 1.95e-05 | 164 | 130 | 8 | IPR019775 | |
| Domain | Gal_Oxase/kelch_b-propeller | 5.60e-05 | 59 | 130 | 5 | IPR011043 | |
| Domain | BACK | 6.08e-05 | 60 | 130 | 5 | SM00875 | |
| Domain | BACK | 6.58e-05 | 61 | 130 | 5 | IPR011705 | |
| Domain | BACK | 6.58e-05 | 61 | 130 | 5 | PF07707 | |
| Domain | ASX_HYDROXYL | 7.07e-05 | 100 | 130 | 6 | PS00010 | |
| Domain | Gal_Oxidase_b-propeller | 8.84e-05 | 34 | 130 | 4 | IPR015916 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.78e-05 | 106 | 130 | 6 | IPR000152 | |
| Domain | Kinesin_motor_CS | 1.86e-04 | 41 | 130 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.24e-04 | 43 | 130 | 4 | IPR027640 | |
| Domain | - | 2.45e-04 | 44 | 130 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 2.45e-04 | 44 | 130 | 4 | PF00225 | |
| Domain | KISc | 2.45e-04 | 44 | 130 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.45e-04 | 44 | 130 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.45e-04 | 44 | 130 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.45e-04 | 44 | 130 | 4 | PS50067 | |
| Domain | SHR-BD | 2.86e-04 | 4 | 130 | 2 | IPR009543 | |
| Domain | VPS13_C | 2.86e-04 | 4 | 130 | 2 | PF16909 | |
| Domain | VPS13_C | 2.86e-04 | 4 | 130 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.86e-04 | 4 | 130 | 2 | PF06650 | |
| Domain | - | 3.44e-04 | 48 | 130 | 4 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 5.81e-04 | 55 | 130 | 4 | IPR015915 | |
| Domain | PDZ | 5.96e-04 | 148 | 130 | 6 | SM00228 | |
| Domain | - | 6.39e-04 | 150 | 130 | 6 | 2.30.42.10 | |
| Domain | PDZ | 6.62e-04 | 151 | 130 | 6 | PS50106 | |
| Domain | PDZ | 6.85e-04 | 152 | 130 | 6 | IPR001478 | |
| Domain | Laminin_G | 7.11e-04 | 58 | 130 | 4 | IPR001791 | |
| Domain | - | 8.53e-04 | 27 | 130 | 3 | 2.130.10.80 | |
| Domain | Syndecan | 9.87e-04 | 7 | 130 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 9.87e-04 | 7 | 130 | 2 | IPR027789 | |
| Domain | EGF | 1.30e-03 | 235 | 130 | 7 | SM00181 | |
| Domain | Chorein_N | 1.31e-03 | 8 | 130 | 2 | PF12624 | |
| Domain | Calx_beta | 1.31e-03 | 8 | 130 | 2 | SM00237 | |
| Domain | VPS13_N | 1.31e-03 | 8 | 130 | 2 | IPR026854 | |
| Domain | Plexin_repeat | 1.41e-03 | 32 | 130 | 3 | IPR002165 | |
| Domain | PSI | 1.41e-03 | 32 | 130 | 3 | PF01437 | |
| Domain | Calx_beta | 1.68e-03 | 9 | 130 | 2 | IPR003644 | |
| Domain | LisH | 1.68e-03 | 9 | 130 | 2 | PF08513 | |
| Domain | Calx-beta | 1.68e-03 | 9 | 130 | 2 | PF03160 | |
| Domain | EGF-like_dom | 1.81e-03 | 249 | 130 | 7 | IPR000742 | |
| Domain | MIP_CS | 2.09e-03 | 10 | 130 | 2 | IPR022357 | |
| Domain | Rap_GAP | 2.09e-03 | 10 | 130 | 2 | PF02145 | |
| Domain | SKP1/BTB/POZ | 2.10e-03 | 189 | 130 | 6 | IPR011333 | |
| Domain | BTB | 2.24e-03 | 131 | 130 | 5 | PF00651 | |
| Domain | LAM_G_DOMAIN | 2.33e-03 | 38 | 130 | 3 | PS50025 | |
| Domain | Rap_GAP_dom | 2.54e-03 | 11 | 130 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.54e-03 | 11 | 130 | 2 | PS50085 | |
| Domain | Laminin_G_2 | 2.70e-03 | 40 | 130 | 3 | PF02210 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.03e-03 | 12 | 130 | 2 | IPR011041 | |
| Domain | EGF_CA | 3.06e-03 | 86 | 130 | 4 | PF07645 | |
| Domain | PDZ | 3.07e-03 | 141 | 130 | 5 | PF00595 | |
| Domain | PSI | 3.54e-03 | 44 | 130 | 3 | IPR016201 | |
| Domain | LamG | 3.54e-03 | 44 | 130 | 3 | SM00282 | |
| Domain | PSI | 4.02e-03 | 46 | 130 | 3 | SM00423 | |
| Domain | MIP | 4.14e-03 | 14 | 130 | 2 | PF00230 | |
| Domain | MIP | 4.14e-03 | 14 | 130 | 2 | PS00221 | |
| Domain | Neurexin-like | 4.14e-03 | 14 | 130 | 2 | IPR003585 | |
| Domain | 4.1m | 4.14e-03 | 14 | 130 | 2 | SM00294 | |
| Domain | ConA-like_dom | 4.34e-03 | 219 | 130 | 6 | IPR013320 | |
| Domain | EGF_Ca-bd_CS | 4.71e-03 | 97 | 130 | 4 | IPR018097 | |
| Domain | - | 4.76e-03 | 15 | 130 | 2 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 4.76e-03 | 15 | 130 | 2 | IPR023271 | |
| Domain | MIP | 4.76e-03 | 15 | 130 | 2 | IPR000425 | |
| Domain | EGF_CA | 5.07e-03 | 99 | 130 | 4 | PS01187 | |
| Domain | CUB | 5.09e-03 | 50 | 130 | 3 | SM00042 | |
| Domain | BTB | 5.26e-03 | 160 | 130 | 5 | PS50097 | |
| Domain | - | 5.68e-03 | 52 | 130 | 3 | 2.60.120.290 | |
| Domain | CUB | 5.99e-03 | 53 | 130 | 3 | PS01180 | |
| Domain | Quinoprotein_ADH-like_supfam | 5.99e-03 | 53 | 130 | 3 | IPR011047 | |
| Domain | EGF_3 | 6.08e-03 | 235 | 130 | 6 | PS50026 | |
| Domain | Aminotran_1_2 | 6.11e-03 | 17 | 130 | 2 | PF00155 | |
| Domain | Aminotransferase_I/II | 6.11e-03 | 17 | 130 | 2 | IPR004839 | |
| Domain | Rib_L2_dom2 | 6.84e-03 | 18 | 130 | 2 | IPR014722 | |
| Domain | - | 6.84e-03 | 18 | 130 | 2 | 2.30.30.30 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MPST ATP6V1A COL6A3 MXRA5 NT5E GPT ADCY1 FAH VPS13D FAT1 PTPN13 FCGBP MEGF8 ASL PKD2 CRNN TAOK1 GNB1 PATJ | 1.40e-08 | 1016 | 134 | 19 | 19056867 |
| Pubmed | KIF21B RANBP2 KIF23 TRIO KIF21A DVL2 GRIK2 SIPA1 DCTN1 TBL1XR1 LRIG2 CCDC13 AGO3 NRXN1 DCHS1 HERC2 GNB1 TBL1X | 3.52e-08 | 963 | 134 | 18 | 28671696 | |
| Pubmed | KIF21B ATP6V1A RANBP2 KIF23 NT5E SMCHD1 F2 RUVBL2 SF1 NUP205 CSTF1 ACIN1 GNB1 KPNA2 | 2.89e-07 | 660 | 134 | 14 | 32780723 | |
| Pubmed | 5.28e-07 | 41 | 134 | 5 | 23676014 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO POLRMT RAP1GAP2 FGFRL1 EML2 PFAS ST3GAL1 LRRK1 PIP5K1C DCTN1 FAT1 HEG1 MEGF8 FURIN NADK HERC2 ARHGAP33 | 1.30e-06 | 1105 | 134 | 17 | 35748872 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 KIF23 GALE PDPR KIF21A DVL2 RNF213 PFAS DCTN1 TBL1XR1 RUVBL2 SF1 NUP205 FCGBP HIBCH ACIN1 GNB1 HSD17B11 KPNA2 | 1.33e-06 | 1367 | 134 | 19 | 32687490 |
| Pubmed | GPT SPTLC1 DVL2 POLRMT RNF213 SIPA1 SQOR RUVBL2 ABCA8 ACTL7A FAT1 AGO3 BRPF1 CRNN DDX41 ARHGAP33 ALG13 | 1.49e-06 | 1116 | 134 | 17 | 31753913 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP6V1A RANBP2 KIF23 KIF27 TRIO SMCHD1 SPTLC1 POLRMT PFAS F2 DCTN1 RUVBL2 SF1 NUP205 CSTF1 ACIN1 GNB1 DDX41 KPNA2 | 2.45e-06 | 1425 | 134 | 19 | 30948266 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RANBP2 TRIO IFT172 SMCHD1 GRIK2 F2 PIP5K1C TBL1XR1 AGO3 HERC2 GNB1 | 2.50e-06 | 475 | 134 | 11 | 31040226 |
| Pubmed | WHRN IFT172 RAP1GAP2 PIP5K1C KLHL29 MEGF8 ACIN1 PCDH10 VPS13B PLXNA2 | 4.34e-06 | 407 | 134 | 10 | 12693553 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 6.58e-06 | 10 | 134 | 3 | 15345741 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | RANBP2 TRIO SMCHD1 SPTLC1 DCTN1 RUVBL2 PTPN13 CSTF1 ACIN1 HERC2 GNB1 PATJ PCDH10 KPNA2 | 1.38e-05 | 922 | 134 | 14 | 27609421 |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 10225949 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 1.47e-05 | 2 | 134 | 2 | 9430716 | |
| Pubmed | TBL1X: At the crossroads of transcriptional and posttranscriptional regulation. | 1.47e-05 | 2 | 134 | 2 | 36206873 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19658047 | ||
| Pubmed | Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung. | 1.47e-05 | 2 | 134 | 2 | 11165019 | |
| Pubmed | SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth. | 1.47e-05 | 2 | 134 | 2 | 27129164 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18678926 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAM234A SPTLC1 RNF213 ST3GAL1 GRIK2 SLC35B2 LRIG2 FAT1 GORASP2 HEG1 MEGF8 FURIN PKD2 NADK ECEL1 DCAF12 | 1.65e-05 | 1201 | 134 | 16 | 35696571 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATP6V1A TRIO TMPRSS6 ENC1 FGFRL1 RNF213 ST3GAL1 GRIK2 TBL1XR1 ADCY1 KLHL29 PTPN13 PLXDC2 PKD2 PATJ VPS13B TBL1X KLHL26 | 1.74e-05 | 1489 | 134 | 18 | 28611215 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TRAPPC11 RANBP2 MRI1 PDPR SPTLC1 POLRMT PFAS DCTN1 TBL1XR1 RUVBL2 NUP205 GNB1 | 1.92e-05 | 704 | 134 | 12 | 29955894 |
| Pubmed | 2.26e-05 | 87 | 134 | 5 | 37495603 | ||
| Pubmed | ATP6V1A RANBP2 KIF23 GALE NT5E KIF21A PFAS DCTN1 TBL1XR1 RUVBL2 SF1 ACIN1 GNB1 PATJ TBL1X KPNA2 | 2.60e-05 | 1247 | 134 | 16 | 27684187 | |
| Pubmed | ATP6V1A FAM234A SMCHD1 SPTLC1 RUVBL2 NUP205 LRIG2 MEGF8 SUSD1 ECEL1 HSD17B11 | 2.71e-05 | 613 | 134 | 11 | 22268729 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ATP6V1A RANBP2 TRIO DVL2 DCTN1 RUVBL2 NUP205 AGO3 BRPF1 NADK HERC2 GNB1 DDX41 | 2.74e-05 | 853 | 134 | 13 | 28718761 |
| Pubmed | 3.02e-05 | 16 | 134 | 3 | 16880404 | ||
| Pubmed | 3.66e-05 | 17 | 134 | 3 | 27779093 | ||
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 4.23e-05 | 50 | 134 | 4 | 24769233 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 38891114 | ||
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 4.41e-05 | 3 | 134 | 2 | 25204870 | |
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 4.41e-05 | 3 | 134 | 2 | 3198591 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 4.41e-05 | 3 | 134 | 2 | 18366090 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 16406382 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 16141002 | ||
| Pubmed | A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. | 4.41e-05 | 3 | 134 | 2 | 12629167 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 31005376 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20301676 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 3665927 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24443028 | ||
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 4.41e-05 | 3 | 134 | 2 | 26446217 | |
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 4.41e-05 | 3 | 134 | 2 | 15563506 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 4.41e-05 | 3 | 134 | 2 | 11944992 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 4.41e-05 | 3 | 134 | 2 | 17035546 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 4.41e-05 | 3 | 134 | 2 | 25423136 | |
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 4.41e-05 | 3 | 134 | 2 | 9520112 | |
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 4.41e-05 | 3 | 134 | 2 | 3348212 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 4.41e-05 | 3 | 134 | 2 | 34133920 | |
| Pubmed | Expression of CXCL4 and aquaporin 3 and 10 mRNAs in patients with otitis media with effusion. | 4.41e-05 | 3 | 134 | 2 | 26810286 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24972051 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21459131 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 36982625 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 30858964 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 28013231 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24801232 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24909165 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24310606 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 4.41e-05 | 3 | 134 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 4.41e-05 | 3 | 134 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 4.41e-05 | 3 | 134 | 2 | 29045040 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 7780011 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 38571813 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 35173587 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 4.41e-05 | 3 | 134 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 4.41e-05 | 3 | 134 | 2 | 12011280 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 33626338 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20608975 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 29192630 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 4.41e-05 | 3 | 134 | 2 | 7722633 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 27265621 | ||
| Pubmed | 6.56e-05 | 257 | 134 | 7 | 16335952 | ||
| Pubmed | 7.07e-05 | 21 | 134 | 3 | 37422473 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 USP9Y RUVBL2 SF1 NUP205 PTPN13 NRXN1 CSTF1 ACIN1 MPND GNB1 DDX41 ARHGAP33 KPNA2 | 7.84e-05 | 1082 | 134 | 14 | 38697112 |
| Pubmed | COX20 ATP6V1A SHFL SMCHD1 F2 SQOR RUVBL2 SF1 NUP205 AGO3 ACIN1 TAOK1 TRPM1 HERC2 GNB1 DDX41 | 7.99e-05 | 1371 | 134 | 16 | 36244648 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 32706374 | ||
| Pubmed | Human adipose glycerol flux is regulated by a pH gate in AQP10. | 8.80e-05 | 4 | 134 | 2 | 30420639 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 25556835 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 8786425 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 17347997 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 26313002 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 8.80e-05 | 4 | 134 | 2 | 33888718 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 17650106 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 8.80e-05 | 4 | 134 | 2 | 14983056 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 15498460 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 25413345 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 8806434 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 18193033 | ||
| Pubmed | G-protein-mediated inhibition of the Trp channel TRPM1 requires the Gβγ dimer. | 8.80e-05 | 4 | 134 | 2 | 22586107 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 18374649 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 18761340 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 8.80e-05 | 4 | 134 | 2 | 32134527 | |
| Pubmed | Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. | 8.80e-05 | 4 | 134 | 2 | 15194424 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 KIF27 SMCHD1 KIF21A DCTN1 RUVBL2 ACIN1 TAOK1 DDX41 KPNA2 | 9.10e-05 | 582 | 134 | 10 | 20467437 |
| Pubmed | 1.05e-04 | 120 | 134 | 5 | 27320910 | ||
| Cytoband | 4q22.1 | 9.87e-07 | 26 | 134 | 4 | 4q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q22 | 6.81e-05 | 74 | 134 | 4 | chr4q22 | |
| GeneFamily | WD repeat domain containing | KIF21B IFT172 KIF21A EML2 TBL1XR1 CFAP52 DCAF12L1 CSTF1 GNB1 TBL1X DCAF12 | 1.59e-07 | 262 | 97 | 11 | 362 |
| GeneFamily | Kelch like|BTB domain containing | 2.91e-06 | 42 | 97 | 5 | 617 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.07e-04 | 46 | 97 | 4 | 622 | |
| GeneFamily | PDZ domain containing | 1.68e-04 | 152 | 97 | 6 | 1220 | |
| GeneFamily | Transient receptor potential cation channels | 4.45e-04 | 28 | 97 | 3 | 249 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 7.75e-04 | 134 | 97 | 5 | 861 | |
| GeneFamily | Collagens | 1.92e-03 | 46 | 97 | 3 | 490 | |
| GeneFamily | Aquaporins | 2.49e-03 | 14 | 97 | 2 | 305 | |
| GeneFamily | Cadherin related | 3.68e-03 | 17 | 97 | 2 | 24 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 8.20e-06 | 200 | 132 | 8 | M9933 | |
| Coexpression | GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN | 8.20e-06 | 200 | 132 | 8 | M6485 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | COL6A3 KIF27 RNF213 ST3GAL1 ABCA8 LRIG2 FAH FREM2 HEG1 PTPN13 DCAF12L1 PLXDC2 HSD17B13 KRT20 KLHL8 PATJ PLXNA2 | 6.81e-06 | 797 | 129 | 17 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-07 | 193 | 134 | 8 | d5930f7bd9b299f792212d40a3272a37adf64a82 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.52e-07 | 197 | 134 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-07 | 161 | 134 | 7 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-07 | 161 | 134 | 7 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-07 | 161 | 134 | 7 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-07 | 161 | 134 | 7 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.16e-06 | 178 | 134 | 7 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-06 | 185 | 134 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.13e-06 | 195 | 134 | 7 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.20e-06 | 196 | 134 | 7 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 196 | 134 | 7 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 196 | 134 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 197 | 134 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-06 | 197 | 134 | 7 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.28e-06 | 197 | 134 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-06 | 157 | 134 | 6 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 168 | 134 | 6 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 169 | 134 | 6 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.24e-05 | 169 | 134 | 6 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-05 | 172 | 134 | 6 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 173 | 134 | 6 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 174 | 134 | 6 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 174 | 134 | 6 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 176 | 134 | 6 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 176 | 134 | 6 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 177 | 134 | 6 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 177 | 134 | 6 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 177 | 134 | 6 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.66e-05 | 178 | 134 | 6 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.66e-05 | 178 | 134 | 6 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 180 | 134 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 180 | 134 | 6 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 181 | 134 | 6 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 181 | 134 | 6 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 182 | 134 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 182 | 134 | 6 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-05 | 183 | 134 | 6 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 134 | 6 | a253ad65673fce6cb453e709cb235ce7cbfa18b7 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.95e-05 | 183 | 134 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 134 | 6 | ddc45fb591ba0ce3fa05c08051d58286a89ef835 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.95e-05 | 183 | 134 | 6 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 184 | 134 | 6 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-05 | 184 | 134 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.01e-05 | 184 | 134 | 6 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 185 | 134 | 6 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 185 | 134 | 6 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 185 | 134 | 6 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.13e-05 | 186 | 134 | 6 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.13e-05 | 186 | 134 | 6 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 187 | 134 | 6 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 189 | 134 | 6 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 189 | 134 | 6 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 189 | 134 | 6 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.40e-05 | 190 | 134 | 6 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-05 | 192 | 134 | 6 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.55e-05 | 192 | 134 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 192 | 134 | 6 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 192 | 134 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-05 | 192 | 134 | 6 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-05 | 192 | 134 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 192 | 134 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.62e-05 | 193 | 134 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 193 | 134 | 6 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.62e-05 | 193 | 134 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-05 | 193 | 134 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-05 | 193 | 134 | 6 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-05 | 193 | 134 | 6 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.70e-05 | 194 | 134 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 194 | 134 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 195 | 134 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.78e-05 | 195 | 134 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 195 | 134 | 6 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.86e-05 | 196 | 134 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 196 | 134 | 6 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.86e-05 | 196 | 134 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 196 | 134 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 197 | 134 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.94e-05 | 197 | 134 | 6 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 197 | 134 | 6 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 197 | 134 | 6 | 1018aac22659c081d227d566afa29b1748c18ade | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 197 | 134 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 197 | 134 | 6 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-F|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.94e-05 | 197 | 134 | 6 | fbff2fb7a8142b88c9dc71aa10980f4350b7e081 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-05 | 198 | 134 | 6 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-05 | 198 | 134 | 6 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.03e-05 | 198 | 134 | 6 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-05 | 198 | 134 | 6 | 58f5b5e756ab4aa7234aa8d95fba564d6e8c22d9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 199 | 134 | 6 | beca4c7eb29ac771fd37f30cd23d4dce4afcfff8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 199 | 134 | 6 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 199 | 134 | 6 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 199 | 134 | 6 | cd3ab9a75b40e0d417d53b3d8756fc9bed30ac83 | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; PC3; HT_HG-U133A | 2.34e-06 | 199 | 131 | 9 | 7281_DN | |
| Disease | sensory system disease (implicated_via_orthology) | 5.59e-05 | 3 | 128 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy | 1.11e-04 | 4 | 128 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 1.11e-04 | 4 | 128 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.11e-04 | 4 | 128 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.11e-04 | 4 | 128 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.11e-04 | 4 | 128 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.11e-04 | 4 | 128 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.51e-04 | 447 | 128 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | small integral membrane protein 9 measurement | 2.77e-04 | 6 | 128 | 2 | EFO_0802075 | |
| Disease | Disorder of amino acid metabolism | 5.14e-04 | 8 | 128 | 2 | cv:C0002514 | |
| Disease | Parkinson disease, disease progression measurement | 6.50e-04 | 39 | 128 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | HVA measurement, MHPG measurement | 7.01e-04 | 40 | 128 | 3 | EFO_0005131, EFO_0005133 | |
| Disease | neuritic plaque measurement | 8.49e-04 | 349 | 128 | 7 | EFO_0006798 | |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 8.67e-04 | 43 | 128 | 3 | EFO_0004735, GO_0031427 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.00e-03 | 11 | 128 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 1.41e-03 | 13 | 128 | 2 | EFO_0802114 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 1.64e-03 | 14 | 128 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | central corneal thickness | 2.34e-03 | 309 | 128 | 6 | EFO_0005213 | |
| Disease | response to platinum based chemotherapy | 2.73e-03 | 18 | 128 | 2 | EFO_0004647 | |
| Disease | body weight | SMCHD1 ST3GAL1 GRIK2 ELP3 SQOR SP8 NRXN3 NRXN1 SUSD1 ASL NADK PATJ MAP2K5 | 3.34e-03 | 1261 | 128 | 13 | EFO_0004338 |
| Disease | coagulation factor V measurement | 3.37e-03 | 20 | 128 | 2 | EFO_0008087 | |
| Disease | Intellectual Disability | 3.44e-03 | 447 | 128 | 7 | C3714756 | |
| Disease | Colorectal Carcinoma | 3.60e-03 | 702 | 128 | 9 | C0009402 | |
| Disease | activities of daily living score measurement | 3.71e-03 | 21 | 128 | 2 | EFO_0008451 | |
| Disease | prothrombin time measurement | 3.71e-03 | 21 | 128 | 2 | EFO_0008390 | |
| Disease | rosacea severity measurement | 3.91e-03 | 147 | 128 | 4 | EFO_0009180 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGVEYGSGRGHLGTF | 21 | Q9UKV3 | |
| VVPGSGFGQREGTYH | 451 | P24298 | |
| LYSGSTGHQIGLRGS | 241 | Q9H0X4 | |
| IYGGGFQTGTSSLHV | 141 | P06276 | |
| VGTAYGGSSQIHGAI | 1101 | Q9NP73 | |
| NGHRIGTLSVYGATA | 2666 | Q7Z408 | |
| AVVIYGGTQLGHSIR | 396 | Q9NQI0 | |
| IGKGHRGTVAYVGAT | 36 | Q14203 | |
| ATVGYGILREGGSAV | 31 | Q7L266 | |
| VSGLVVDTGHGVTYT | 191 | Q8TC94 | |
| VTIAIYVGGNVSGAH | 66 | Q96PS8 | |
| GGHTEVVSALLYAGV | 621 | Q9ULJ7 | |
| YGGRNRTVATPSHGV | 421 | Q9H9G7 | |
| ITGAGHGIGRLTAYE | 41 | Q8NBQ5 | |
| ITGAGHGIGRQTTYE | 41 | Q7Z5P4 | |
| VLVSRGGSQSVYGVD | 311 | O15519 | |
| TGGGGVGETKVIYHL | 6 | O14641 | |
| SIVGQSNERGDGGIY | 281 | O14641 | |
| RAEVSGVGYDGQGTV | 401 | O75185 | |
| AGGLTLGARTHNYGI | 96 | Q86Y39 | |
| DITKHDGTGGQSIYG | 3126 | P49792 | |
| GGVGLSVHGQFRVAT | 146 | Q6NVY1 | |
| GGGFQRVRTHLYGSL | 1411 | Q92621 | |
| GEEYSGGVIGKIHAT | 3556 | Q14517 | |
| RAVHAGGTNGPITYS | 2091 | Q96JQ0 | |
| HAGTTYIFSKGGGQI | 86 | P58400 | |
| HAGAVGDRGVVYISG | 466 | Q8N239 | |
| GGGTEGYHVLRVQEN | 11 | Q9H8Y8 | |
| SVLGQGGSGTVIYRA | 1246 | Q38SD2 | |
| GEYGRLGHGDNTTQL | 3126 | O95714 | |
| GHSVEQYGALGGTAR | 431 | P04424 | |
| EGSVVYTHTSGEIGL | 1011 | Q5SZK8 | |
| RHGYRVTGISGATAE | 316 | O95786 | |
| GGITSITLRGEGHQF | 291 | Q8N1V2 | |
| TYTIGGGHIASVVEG | 91 | Q86VH2 | |
| VYLDGHLITTVQGDG | 301 | O95544 | |
| ESGGTMVTITGHYLG | 966 | O75051 | |
| YGAEGRHNSTIDVGG | 286 | Q8N441 | |
| AHDGQRIYILGGGTS | 266 | Q6PID8 | |
| GGVGSVALVNHVYAV | 451 | Q9P2G9 | |
| IRYRDTLGHGNGGTV | 166 | Q13163 | |
| GSHLTVVGIFYGTGV | 251 | P47888 | |
| VICGGGITGTSVAYH | 46 | Q8NCN5 | |
| NGGIYTTGVTSRLIH | 181 | O75037 | |
| SGRYSHVAAVLGGSV | 511 | Q7Z7M0 | |
| GERSIAGISYGQVRG | 526 | Q9ULI3 | |
| SHLTRSEVVGYLGGR | 286 | Q8N594 | |
| VHRYVLTAVDGGGGG | 196 | Q9P2E7 | |
| YVHRIGRTGRSGNTG | 516 | Q9UJV9 | |
| HTVNYGSDLTGGGDL | 51 | P35900 | |
| TEVGRAGKGQHYEGS | 121 | Q9UBG3 | |
| LNYGGIGTIIGHELT | 601 | O95672 | |
| VDLIGGYNIGTVSHE | 471 | Q9UG01 | |
| GHSPGTLGVYVRVNG | 111 | Q92729 | |
| SGGTVEQIVYLVHCG | 406 | P52292 | |
| AHGVVDGIYRLSGVS | 341 | O14559 | |
| LVTGGAGYIGSHTVL | 6 | Q14376 | |
| VLELSGYTRTGGGAV | 766 | Q08828 | |
| RYVGGIGSGQHLKTS | 921 | Q9P2D3 | |
| AGGQHLQYRSGEGAV | 366 | Q53HC5 | |
| RHSILYGSLGSVVAG | 31 | Q5RI15 | |
| GNVRVSRELAGHTGY | 131 | P62873 | |
| LVRVTYVSSEGGHSG | 586 | Q9P218 | |
| VSFYEHIITVGTGQG | 346 | Q5T6F0 | |
| LTYNHGGITGSRGLQ | 276 | Q9Y6R7 | |
| GYTGHGIVVSILDDG | 141 | P09958 | |
| VHYLRNKGVGEGSSG | 456 | Q8IYE1 | |
| TDRVIGGLLAGQTYH | 3041 | P12111 | |
| TGTRVGVVQYSHEGT | 656 | P12110 | |
| GGGVSIVRELHVYGS | 466 | Q9H9T3 | |
| LSFYRHIITVGTGQG | 356 | Q5VU92 | |
| KVYITGGRGSENGVS | 341 | O14682 | |
| RTVAEGHGDTLYVGT | 341 | O95834 | |
| GHGDTLYVGTTRNSI | 346 | O95834 | |
| PVGYHGRASSVVVSG | 156 | P16930 | |
| LVRYTGAGLSGRQVH | 341 | Q05048 | |
| IGYSQGTTHVLRFGG | 26 | Q13002 | |
| IGGGIQSITYTHNGD | 1091 | O00411 | |
| SVTGGVNTSVRHGGI | 1381 | Q12923 | |
| GLLFTYGVTGSGKTH | 106 | Q02241 | |
| GITRIRGTSYQSPHG | 331 | Q9Y230 | |
| GGKHETVGGQLLQSY | 131 | Q4VX76 | |
| RNHYEVLVLGGGSGG | 41 | Q9Y6N5 | |
| AGRLGVGAATHVVIY | 86 | P25325 | |
| FRGGLDVTHGQTGVE | 306 | Q684P5 | |
| TEEDGGGVGHRTVYL | 16 | A6NHR9 | |
| HGDIFTILVGGRYVT | 61 | Q16647 | |
| VSLRGGHAGATYIFG | 76 | Q9HDB5 | |
| GAIQLGIGYTVGHLS | 81 | O60331 | |
| TGEGHQRGQTVGSVG | 356 | Q8TDN2 | |
| TVATGGFIYTGEVVH | 176 | Q6UX71 | |
| QGHGRYPSTGILSVI | 261 | Q11201 | |
| EGSGGGTLHSYRVIV | 251 | Q96FS4 | |
| DHGVGRTGTVNSVGS | 336 | Q7L7X3 | |
| AGYGTALGVIRSLHS | 176 | Q9BV20 | |
| IRGGSEHGVGIYVSL | 156 | Q9P202 | |
| TQTGALVHSYRGTGG | 471 | Q9BZK7 | |
| VLGEHGRGVTEHYGI | 281 | O15269 | |
| HTSVDGLQGIYPRVG | 166 | Q8IXZ3 | |
| STGRHIYFTLVTEGG | 66 | Q9Y5J5 | |
| IYEGQITAILGHSGA | 506 | O94911 | |
| RTSGLVVEVGHGVSY | 211 | Q9Y615 | |
| RYGQSTGEFLQVGGI | 441 | P21589 | |
| YSVGTGRGVGHSMVR | 1051 | P55201 | |
| VDGRVGLLGNTYHGS | 191 | Q9NY30 | |
| GSVAQVVLSRGTHGG | 41 | Q92482 | |
| SGNLVHSYRGTGGIF | 536 | O60907 | |
| GSDHTGVGRSIVYGV | 36 | Q9NUL5 | |
| GGIHGRSNDGAYSLV | 476 | Q96PU4 | |
| SRVGRGTAYVGFHGG | 3421 | Q63HN8 | |
| GLRLIHYSVGEGTTA | 61 | A0A0J9YXY3 | |
| GNIEGGVATGHYIIS | 971 | Q7Z392 | |
| KHISEQRAGYGGTGS | 206 | Q9NZQ8 | |
| GLRLIHYSVGEGTTA | 61 | P0DPF7 | |
| YGHTVTVVGGLGVAV | 386 | Q8TB61 | |
| LGIRIVGYVGTSHTG | 376 | Q8NI35 | |
| VGYVGTSHTGEASGI | 381 | Q8NI35 | |
| RIHEDSTGGIYTVGV | 176 | Q7Z4S6 | |
| SSIEEGYLLGGHVVR | 211 | Q15413 | |
| VGNHSSRLGGVARYV | 251 | Q6UWL2 | |
| VYRIGVGGGAASSVQ | 456 | O15067 | |
| LRVGSHITGGDIYGI | 141 | P38606 | |
| GGTKYRLVGVLVHSG | 1861 | O00507 | |
| VSSVGARSRGLGGYH | 131 | Q13563 | |
| FTGGVSTGVISHVGD | 136 | Q7Z4N2 | |
| LVSQTGYGILHGAGL | 3816 | Q7Z7G8 | |
| GLGTNYRGHVNITRS | 111 | P00734 | |
| GLRLIHYSNTAGTTG | 61 | A0A1B0GX49 | |
| LGSTPVGSGVYRLHQ | 451 | Q15637 | |
| TSPIEYQRNHSGGGG | 2281 | O75962 | |
| SQISLTGPGVRVHYG | 436 | Q8IU80 | |
| RETYGHLSALGIGGN | 56 | Q96H86 | |
| LYAHRVGRGVSIGST | 166 | Q8NFZ6 | |
| YGNVGGLIRNVTHGV | 4091 | Q5THJ4 | |
| YTLGGLGVAGNVDHV | 686 | Q96CT2 | |
| GYIHKGTDGGTGTRV | 886 | O94898 | |
| TVDGTARGGGVHYED | 561 | Q9UPR5 | |
| YGNRITVHGNGSLDI | 2491 | Q9NR99 |